These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33829865)

  • 1. PRMT5 Promotes EMT Through Regulating Akt Activity in Human Lung Cancer.
    Huang J; Zheng Y; Zheng X; Qian B; Yin Q; Lu J; Lei H
    Cell Transplant; 2021; 30():9636897211001772. PubMed ID: 33829865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades.
    Yan Y; Zhao P; Wang Z; Liu Z; Wang Z; Zhang J; Ding Y; Hua X; Yu L
    Aging (Albany NY); 2021 Jan; 13(3):4468-4481. PubMed ID: 33495409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells.
    Ge L; Wang H; Xu X; Zhou Z; He J; Peng W; Du F; Zhang Y; Gong A; Xu M
    J Cell Mol Med; 2020 Jan; 24(2):1969-1979. PubMed ID: 31851779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth.
    Zhang S; Ma Y; Hu X; Zheng Y; Chen X
    J Cell Mol Med; 2019 Feb; 23(2):1333-1342. PubMed ID: 30461193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRMT5 Promotes Human Lung Cancer Cell Apoptosis via Akt/Gsk3β Signaling Induced by Resveratrol.
    Li Y; Yang Y; Liu X; Long Y; Zheng Y
    Cell Transplant; 2019 Dec; 28(12):1664-1673. PubMed ID: 31665911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis.
    Zheng Y; Lu J; Hu X; Hu X; Gao X; Zhou J
    Technol Cancer Res Treat; 2023; 22():15330338231161139. PubMed ID: 36927233
    [No Abstract]   [Full Text] [Related]  

  • 7. PRMT5 facilitates angiogenesis and EMT via HIF-1α/VEGFR/Akt signaling axis in lung cancer.
    Zheng Y; Ji H; Yi W; Chen Z; Hu X; Zhou J; Wang Y; Zheng X
    Aging (Albany NY); 2023 Jul; 15(13):6163-6178. PubMed ID: 37400960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth.
    Liu L; Yan H; Ruan M; Yang H; Wang L; Lei B; Sun X; Chang C; Huang G; Xie W
    Cancer Sci; 2021 Aug; 112(8):3083-3098. PubMed ID: 34033176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade.
    Wei TY; Juan CC; Hisa JY; Su LJ; Lee YC; Chou HY; Chen JM; Wu YC; Chiu SC; Hsu CP; Liu KL; Yu CT
    Cancer Sci; 2012 Sep; 103(9):1640-50. PubMed ID: 22726390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
    Chung J; Karkhanis V; Baiocchi RA; Sif S
    J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
    Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
    Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRMT5 activates KLF5 by methylation to facilitate lung cancer.
    Zhou H; Chang J; Zhang J; Zheng H; Miao X; Mo H; Sun J; Jia Q; Qi G
    J Cell Mol Med; 2024 Mar; 28(5):e17856. PubMed ID: 37461162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
    Chen H; Lorton B; Gupta V; Shechter D
    Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.
    Ibrahim R; Matsubara D; Osman W; Morikawa T; Goto A; Morita S; Ishikawa S; Aburatani H; Takai D; Nakajima J; Fukayama M; Niki T; Murakami Y
    Hum Pathol; 2014 Jul; 45(7):1397-405. PubMed ID: 24775604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation.
    Sheng X; Wang Z
    BMC Cancer; 2016 Aug; 16():567. PubMed ID: 27480244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein arginine methyltransferase 5 is essential for growth of lung cancer cells.
    Gu Z; Gao S; Zhang F; Wang Z; Ma W; Davis RE; Wang Z
    Biochem J; 2012 Sep; 446(2):235-41. PubMed ID: 22708516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRMT5 activates AKT via methylation to promote tumor metastasis.
    Huang L; Zhang XO; Rozen EJ; Sun X; Sallis B; Verdejo-Torres O; Wigglesworth K; Moon D; Huang T; Cavaretta JP; Wang G; Zhang L; Shohet JM; Lee MM; Wu Q
    Nat Commun; 2022 Jul; 13(1):3955. PubMed ID: 35803962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.